Abstract
Keywords
Introduction
Type A aortic dissection (TAAD) is lethal unless the ascending aorta is immediately repaired. 1 Thoracic endovascular aortic repair (TEVAR) is a minimally invasive treatment option for this type of aortic dissection,2–4 but a dissected native ascending aorta is vulnerable, and a dedicated stent-graft is required to avoid further iatrogenic dissection and the associated devastating outcome. 5 The Zenith Ascend TAA Endovascular Graft (Cook Medical Europe, Bjaeverskov, Denmark) was specially designed for ascending aortic pathologies. The device is not approved and has been employed as a custom-made device for compassionate use cases. Its application as a standalone device is restricted by the need for a healthy distal landing zone proximal to the innominate artery. However, the dissection flap is rarely limited to the ascending aorta and usually extends downstream. According to a German registry of TAAD patients, 6 distal involvement of the arch was found in 77%, with 50% extending to the descending thoracic aorta and 38% to the abdominal aorta.
The distal landing zone problem can be solved using an inner branched arch device (Cook Medical Europe), which could effectively reline the true lumen to the descending thoracic aorta or lower, improving the chance for aortic remodeling. The anatomical applicability of endovascular repair for acute TAAD has been estimated to be 32% using a short tubular stent-graft alone and 50% if a multibranched stent-graft is additionally applied.7,8 However, the modular use of tubular and branched stent-grafts in TAAD has been reported only rarely.9,10 Our institution has performed 5 endovascular TAAD repairs using this modular strategy; 2 cases were reported previously, 9 and 3 additional patients have been added. The anatomical selection criteria, operative planning, technique, and patient outcomes are presented.
Case Reports
Five patients (mean age 66 years, range 52–78; 4 men) with type A aortic dissection and insufficient distal landing zones were treated with the Zenith Ascend TAA Endovascular Graft and branched arch devices to extend the distal landing zone to maximize the chance for optimal aortic remodeling. Two patients presented acutely and required urgent treatment. Patient comorbidities, prior aortic surgeries, and the stent-grafts implanted are listed in Table 1. The need for ethics approval or patient consent for retrospective collection and analysis of the anonymized data was waived.
Patient Characteristics and Outcomes.
Abbreviations: AF, atrial fibrillation; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CMD, custom-made device; COPD, chronic obstructive pulmonary disease; F, female; FL, false lumen; HLD, hyperlipidemia; HTN, hypertension; IA, innominate artery; LCCA, left common carotid artery; LSA, left subclavian artery; M, male; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty; SIRS, systemic inflammatory response syndrome.
Investigational Devices
The custom-made Zenith Ascend stent-graft is a single-component tubular or tapering stent-graft constructed of woven polyester fabric sewn to self-expanding nitinol stents with braided polyester and monofilament polypropylene suture. Uncovered stents are incorporated on both the proximal and distal ends to improve alignment and fixation; the lack of hooks and barbs reduces the risk for iatrogenic dissection at the interface between the proximal stent and the wall of the ascending aorta. 5 Four radiopaque markers are placed within 1 mm of the graft fabric edge proximally and distally. The device is currently produced with proximal diameters of 28 to 50 mm.
The custom-made Zenith inner branched arch stent-graft is composed of a woven polyester fabric sewn to stainless steel and nitinol stents. Two inner branches are used to attach bridging covered stents coming from the targeted supra-aortic vessels, most commonly the innominate and left common carotid arteries. 11 The device is currently manufactured with proximal diameters of 34 to 46 mm.
Planning and Operative Technique
All elective patients were discussed by a multidisciplinary team consisting of a cardiologist, a cardiothoracic surgeon, a vascular surgeon, and an anesthetist. Endovascular repair was offered when open surgery was not indicated owing to patient comorbidities. Patients were informed that the investigational devices were being used on a compassionate basis and gave written informed consent.
Thin-slice, arterial-phase computed tomography angiography (CTA) scans were analyzed with the Aquarius iNtuition workstation (TeraRecon Inc, San Mateo, CA, USA) to provide dimensions for stent-graft customization. To apply this technique, the beginning of the entry tear in the ascending aorta must be at least 2 cm from any coronary orifice to allow a sufficient proximal landing zone. The ascending stent-graft can be in tubular or tapering configuration depending on the size of the ascending aorta. The outer wall to outer wall diameter should not measure >40 mm or <24 mm. Adequate oversizing of 15% to 30% is required due to marked pulsatility of the ascending aorta. The branched arch device is designed to accommodate the distal diameter of the ascending stent-graft, its own distal landing zone, and the diameters, lengths, and clock position of the supra-aortic vessels. Overlap between the ascending stent-graft and the branched device is preferably 2 full stents or more. Distal aortic extension stent-grafts as well as false lumen occlusion devices are used as necessary.
Cervical debranching in the form of left carotid–subclavian bypass was undertaken in a staged or simultaneous setting depending on the urgency of the condition. Endovascular procedures were performed under general anesthesia in a hybrid theatre with fixed fluoroscopy and 3-dimensional fusion imaging (Allura Xper and AlluraClarity; Philips Healthcare, Best, the Netherlands). The stent-grafts were preflushed with CO2 before saline flushing to reduce the amount of trapped air in the sheath. 12 The main access was transfemoral, while supra-aortic vessels were accessed through a right common carotid artery cutdown and a percutaneous left brachial artery puncture. A double-curved extended Lunderquist extra-stiff wire (Cook Medical Europe) was positioned in the left ventricle. An occlusion balloon in the inferior vena cava was inflated to reduce cardiac output as the Ascend stent-graft was deployed distal to all coronary orifices and proximal to the innominate trunk. The branched device was then placed with sufficient overlap of the proximal stent-graft and alignment of the branch markers to the targeted supra-aortic vessels. Cannulation and bridging of the supra-aortic branches from the inner branches were performed as previously described. 11
Postoperatively, patients were monitored in an intensive care setting before being transferred to the general ward. An early CTA was arranged before hospital discharge; in the absence of endoleaks, the surveillance CTA scans were scheduled for annually thereafter.
Patient Outcomes
All patients underwent left carotid–subclavian bypass, with the inner branches targeting the innominate trunk and left common carotid artery. Spinal drainage was employed for the 3 elective procedures. Mean operating time was 292±83 minutes (range 200–380) and mean fluoroscopy time was 35±19 minutes (range 15–65), with a dose area product of 599±469 Gy·cm2 (range 136–1193). Technical success (no type I or III endoleak and successful revascularization of all supra-aortic vessels) was achieved in all patients. Median intensive care unit stay was 5 days (range 4–23) and the median hospital stay was 16 days (range 8–25).
One patient with acute dissection and disseminated breast cancer died of pneumonia on day 23. Other perioperative complications included individual cases of major stroke, systemic inflammatory response syndrome, and groin lymphatic leakage. The major stroke was a cerebellar hemorrhage, likely due to the combined effect of systemic anticoagulation and spinal drainage. This patient required surgical external ventricular drainage for decompression of hydrocephalus; he recovered without neurological deficit. The other patient with acute dissection died at 5 months. The 3 elective patients were followed for 7, 13, and 19 months, respectively. All had false lumen thrombosis (Figure 1) with either reduced or stable aneurysm diameters.

A 52-year-old man (patient 5) with chronic type A dissection and a saccular false lumen ascending aortic aneurysm measuring 62 mm. (A) The dissection extended to the abdominal aorta. (B) He was treated with modular ascending and inner branched arch stent-grafts and false lumen occlusion. (C) The ascending stent-graft landed just distal to the coronary ostia. (D) The false lumen was completely thrombosed, and the aneurysm shrank after the operation.
Discussion
The ascending aorta is viewed as the last frontier in TEVAR because of the lengthy distance from a transfemoral access, marked discrepancy between the inner and outer curves, and its close proximity to vital structures including the heart, aortic valve, coronary ostia, and supra-aortic vessels. 13 The Zenith Ascend graft was designed for this region, with a 100-cm-long introducer sheath, a flexible soft tip, and fixating bare stents on both ends with 3 circumferential sutures (Pro-Form; Cook) to allow minor repositioning after retraction of the sheath and to reduce the windsock effect. The stent-graft has no barbs, minimizing iatrogenic trauma to a dissected aorta. Associated use of the branched arch device can effectively extend the distal landing zone to the descending thoracic aorta or more caudally.
Controversy exists as to the extent of repair in open surgery for acute TAAD. The higher risk of more extensive repair such as total arch replacement or frozen elephant trunk has been rewarded with more favorable and longer lasting aortic remodeling.14,15 A meta-analysis demonstrated an acceptable 8.6% [95% confidence interval (CI) 7.2% to 10.0%] overall pooled hospital mortality for the extended arch technique. 14 The pooled rate of stroke was 5.7% (95% CI 3.6% to 8.2%) and the estimate of spinal cord ischemia was 2.0% (95% CI 1.2% to 3.0%). 14 Given the lower immediate operative risk of endovascular repair, it may be reasonable to expect a preference toward more extensive repair in one operative session for better aortic remodeling.
The first 2 patients with acute TAAD were reported previously to demonstrate feasibility of the procedure, but follow-up was short, with 1 in-hospital death. 9 The current study adds 3 patients with chronic dissection and false lumen. Despite the associated operative risks, the procedures led to favorable aortic remodeling in follow-up, with false lumen thrombosis in 3 patients and aneurysm regression in 2.
Both ascending and branched arch stent-grafts still require custom manufacture spanning several weeks, which limits their applicability since most TAAD patients present acutely or are symptomatic. For those requiring urgent treatment, stent-grafts of suitable size destined for other patients can be used.
Conclusion
The results of these advanced endovascular techniques cannot be generalized to other centers, especially those without a hybrid operating suite. However, this limited experience demonstrates the feasibility and safety of combining the Ascend stent-graft with the branched arch device. This combined strategy may sometimes be more beneficial than either device in a standalone application.
Footnotes
Declaration of Conflicting Interests
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Nikolaos Tsilimparis and Tilo Kölbel are proctors for Cook Medical. Tilo Kölbel received research and travel grants from and has intellectual property with Cook Medical.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
